安徽医学
安徽醫學
안휘의학
ANHUI MEDICAL JOURNAL
2014年
7期
872-874,875
,共4页
马宁帅%陈飞%温琥玲%顾华见%何宗喜%王文君%李素平
馬寧帥%陳飛%溫琥玲%顧華見%何宗喜%王文君%李素平
마저수%진비%온호령%고화견%하종희%왕문군%리소평
131 I断层图像融合%甲状腺癌%131 I治疗
131 I斷層圖像融閤%甲狀腺癌%131 I治療
131 I단층도상융합%갑상선암%131 I치료
SPECT/CT fusion imaging%Differentiated thyroid cancer%131 I therapy
目的:评价治疗剂量的131 I-SPECT/CT断层融合显像检测血清甲状腺球蛋白升高(Tg+)而诊断剂量131 I全身显像阴性(Dx-WBS-)的分化型甲状腺癌(DTC)转移灶的价值。方法回顾性分析49例血清Tg+DxWBS-的DTC患者(滤泡状2例,乳头状47例),给予盲法大剂量131 I(7400MBq)治疗后第7天行131 I-全身显像(Rx-WBS)和头颈部、胸部131 I-SPECT/CT断层融合显像,在病灶水平分析131 I-SPECT/CT断层融合图像对 DTC 定位和定性诊断情况。结果治疗剂量131 I 全身显像显示阳性病例16例(32.7%),其中甲状腺残留1例,转移灶15例(30.6%)。经过131 I-SPECT/CT断层融合显像均检测出上述转移灶,同时新发现6例患者的转移灶,转移灶检出率42.9%。结论 Rx-WBS可检测出部分Tg+DxWBS-的DTC患者的转移灶;对Tg+DxWBS-的DTC患者常规行头颈部、胸部131 I-SPECT/CT断层融合图像可提高Tg+DxWBS-的DTC患者的转移灶的诊断准确率。
目的:評價治療劑量的131 I-SPECT/CT斷層融閤顯像檢測血清甲狀腺毬蛋白升高(Tg+)而診斷劑量131 I全身顯像陰性(Dx-WBS-)的分化型甲狀腺癌(DTC)轉移竈的價值。方法迴顧性分析49例血清Tg+DxWBS-的DTC患者(濾泡狀2例,乳頭狀47例),給予盲法大劑量131 I(7400MBq)治療後第7天行131 I-全身顯像(Rx-WBS)和頭頸部、胸部131 I-SPECT/CT斷層融閤顯像,在病竈水平分析131 I-SPECT/CT斷層融閤圖像對 DTC 定位和定性診斷情況。結果治療劑量131 I 全身顯像顯示暘性病例16例(32.7%),其中甲狀腺殘留1例,轉移竈15例(30.6%)。經過131 I-SPECT/CT斷層融閤顯像均檢測齣上述轉移竈,同時新髮現6例患者的轉移竈,轉移竈檢齣率42.9%。結論 Rx-WBS可檢測齣部分Tg+DxWBS-的DTC患者的轉移竈;對Tg+DxWBS-的DTC患者常規行頭頸部、胸部131 I-SPECT/CT斷層融閤圖像可提高Tg+DxWBS-的DTC患者的轉移竈的診斷準確率。
목적:평개치료제량적131 I-SPECT/CT단층융합현상검측혈청갑상선구단백승고(Tg+)이진단제량131 I전신현상음성(Dx-WBS-)적분화형갑상선암(DTC)전이조적개치。방법회고성분석49례혈청Tg+DxWBS-적DTC환자(려포상2례,유두상47례),급여맹법대제량131 I(7400MBq)치료후제7천행131 I-전신현상(Rx-WBS)화두경부、흉부131 I-SPECT/CT단층융합현상,재병조수평분석131 I-SPECT/CT단층융합도상대 DTC 정위화정성진단정황。결과치료제량131 I 전신현상현시양성병례16례(32.7%),기중갑상선잔류1례,전이조15례(30.6%)。경과131 I-SPECT/CT단층융합현상균검측출상술전이조,동시신발현6례환자적전이조,전이조검출솔42.9%。결론 Rx-WBS가검측출부분Tg+DxWBS-적DTC환자적전이조;대Tg+DxWBS-적DTC환자상규행두경부、흉부131 I-SPECT/CT단층융합도상가제고Tg+DxWBS-적DTC환자적전이조적진단준학솔。
Objective To compare 131 I whole body scan(Rx-WBS)and SPECT/CT imaging after131 I therapy for detecting metastatic lesions from differentiated thyroid carcinoma in patients with thyroglobulin elevation but negative iodine scintigraphy.Methods This study re-viewed 49 patients with thyroglobulin elevation but negative iodine scintigraphy from differentiated thyroid carcinoma[1 1 men and 39 women, 2 follicular and 47 papillary thyroid cancer,age 12~73(46 ±17)years]who underwent Rx-WBS and SPECT/CT imaging after 131 I therapy (7 days after administration).The dosage of 131 I were 7400MBq.Investigated the utility of post-therapeutic SPECT/CT imaging for detecting metastatic lesions.Results In the visual analysis,Rx-WBS show the lesions of 16 patients(32.7%):Thyroid remnants in 1 patient,distant metastasis in 15 patients(30.6%),Including the lymph node metastases in 1 1 patients (3 cases for multiple lesions),lung metastasis in 1 patient,and bone metastasis in 1 patient,2 cases of suspicious lesions.Through 131 I-SPECT/CT fusion image,All of the above Positive lesions were detected;6 cases with metastatic lesions were new found(42% detection rate of metastases).Conclusions Rx-WBS can increase the detection of metastases in patient with DTC with thyroglobulin elevation but negative iodine scintigraphy.Delayed post-therapeutic SPECT/CT fusion imaging showed a higher detection rate than Rx-WBS.